Benjamin G. Vincent - Publications

Affiliations: 
Department of Microbiology and Immunology University of North Carolina, Chapel Hill, Chapel Hill, NC 
Website:
https://unclineberger.org/directory/benjamin-vincent/

69 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Routh ED, Woodcock MG, Beckabir W, Vensko SP, Serody JS, Vincent BG. Evaluation of tumor antigen-specific antibody responses in patients with metastatic triple negative breast cancer treated with cyclophosphamide and pembrolizumab. Journal For Immunotherapy of Cancer. 11. PMID 36882226 DOI: 10.1136/jitc-2022-005848  0.456
2022 Olsen KS, Jadi O, Dexheimer S, Bortone DS, Vensko SP, Bennett SN, Tang H, Diiorio M, Saran T, Dingfelder D, Zhu Q, Wang Y, Haiman CA, Pooler L, Sheng X, ... ... Vincent B, et al. Shared graft-vs-leukemia minor histocompatibility antigens in DISCOVeRY-BMT. Blood Advances. PMID 36477467 DOI: 10.1182/bloodadvances.2022008863  0.303
2022 Li S, Mirlekar B, Johnson BM, Brickey WJ, Wrobel JA, Yang N, Song D, Entwistle S, Tan X, Deng M, Cui Y, Li W, Vincent BG, Gale M, Pylayeva-Gupta Y, et al. STING-induced regulatory B cells compromise NK function in cancer immunity. Nature. PMID 36198789 DOI: 10.1038/s41586-022-05254-3  0.525
2022 Mirlekar B, Wang Y, Li S, Zhou M, Entwistle S, De Buysscher T, Morrison A, Herrera G, Harris C, Vincent BG, Ting JP, Rashid N, Kim WY, Yeh JJ, Pylayeva-Gupta Y. Balance between immunoregulatory B cells and plasma cells drives pancreatic tumor immunity. Cell Reports. Medicine. 3: 100744. PMID 36099917 DOI: 10.1016/j.xcrm.2022.100744  0.591
2022 Chai S, Smith CC, Kochar TK, Hunsucker SA, Beck W, Olsen KS, Vensko S, Glish GL, Armistead PM, Prins JF, Vincent BG. NeoSplice: a bioinformatics method for prediction of splice variant neoantigens. Bioinformatics Advances. 2: vbac032. PMID 35669345 DOI: 10.1093/bioadv/vbac032  0.727
2022 Nishijima TF, Kardos J, Chai S, Smith CC, Bortone DS, Selitsky SR, Parker JS, Sanoff HK, Lee MS, Vincent BG. Molecular and Clinical Characterization of a Claudin-Low Subtype of Gastric Cancer. Jco Precision Oncology. 1: 1-10. PMID 35172495 DOI: 10.1200/PO.17.00047  0.724
2022 Anders CK, Woodcock MG, Van Swearingen AED, Moore DT, Sambade MJ, Laurie S, Robeson A, Kolupaev O, Cuaboy LA, Garrett AL, McKinnon K, Cowens K, Bortone D, Calhoun BC, Wilkinson AD, ... ... Vincent BG, et al. Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancer. Journal For Immunotherapy of Cancer. 10. PMID 35121644 DOI: 10.1136/jitc-2021-003427  0.592
2022 Downs-Canner SM, Meier J, Vincent BG, Serody JS. B Cell Function in the Tumor Microenvironment. Annual Review of Immunology. PMID 35044794 DOI: 10.1146/annurev-immunol-101220-015603  0.605
2021 Zeidner JF, Vincent BG, Ivanova A, Moore D, McKinnon KP, Wilkinson AD, Mukhopadhyay R, Mazziotta F, Knaus HA, Foster MC, Coombs CC, Jamieson K, Van Deventer H, Webster JA, Prince GT, et al. Phase II Trial of Pembrolizumab after High-Dose Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia. Blood Cancer Discovery. 2: 616-629. PMID 34778801 DOI: 10.1158/2643-3230.BCD-21-0070  0.527
2021 Tschernia NP, Kumar V, Moore DT, Vincent BG, Coombs CC, Van Deventer H, Foster MC, DeZern AE, Luznik L, Riches ML, Serody JS, Gojo I, Zeidner JF. Safety and efficacy of pembrolizumab prior to allogeneic stem cell transplant in Acute Myeloid Leukemia. Transplantation and Cellular Therapy. PMID 34474164 DOI: 10.1016/j.jtct.2021.08.022  0.494
2021 Truong AS, Zhou M, Krishnan B, Utsumi T, Manocha U, Stewart KG, Beck W, Rose TL, Milowsky MI, He X, Smith CC, Bixby LM, Perou CM, Wobker SE, Bailey ST, ... Vincent BG, et al. Entinostat induces antitumor immune responses through immune editing of tumor neoantigens. The Journal of Clinical Investigation. 131. PMID 34396985 DOI: 10.1172/JCI138560  0.772
2021 Smith CC, Olsen KS, Gentry KM, Sambade M, Beck W, Garness J, Entwistle S, Willis C, Vensko S, Woods A, Fini M, Carpenter B, Routh E, Kodysh J, O'Donnell T, ... ... Vincent BG, et al. Landscape and selection of vaccine epitopes in SARS-CoV-2. Genome Medicine. 13: 101. PMID 34127050 DOI: 10.1186/s13073-021-00910-1  0.76
2021 Shiuan E, Reddy A, Dudzinski SO, Lim AR, Sugiura A, Hongo R, Young K, Liu XD, Smith CC, O'Neal J, Dahlman KB, McAlister R, Chen B, Ruma K, Roscoe N, ... ... Vincent BG, et al. Clinical Features and Multiplatform Molecular Analysis Assist in Understanding Patient Response to Anti-PD-1/PD-L1 in Renal Cell Carcinoma. Cancers. 13. PMID 33806963 DOI: 10.3390/cancers13061475  0.755
2021 Min Y, Roche KC, Tian S, Eblan MJ, McKinnon KP, Caster JM, Chai S, Herring LE, Zhang L, Zhang T, DeSimone JM, Tepper JE, Vincent BG, Serody JS, Wang AZ. Author Correction: Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy. Nature Nanotechnology. PMID 33580223 DOI: 10.1038/s41565-021-00864-w  0.491
2021 Xu N, Palmer DC, Robeson AC, Shou P, Bommiasamy H, Laurie SJ, Willis C, Dotti G, Vincent BG, Restifo NP, Serody JS. STING agonist promotes CAR T cell trafficking and persistence in breast cancer. The Journal of Experimental Medicine. 218. PMID 33382402 DOI: 10.1084/jem.20200844  0.648
2020 Eddy JA, Thorsson V, Lamb AE, Gibbs DL, Heimann C, Yu JX, Chung V, Chae Y, Dang K, Vincent BG, Shmulevich I, Guinney J. CRI iAtlas: an interactive portal for immuno-oncology research. F1000research. 9: 1028. PMID 33214875 DOI: 10.12688/f1000research.25141.1  0.321
2020 Wood CG, Ferguson JE, Parker JS, Moore DT, Whisenant JG, Maygarden SJ, Wallen EM, Kim WY, Milowsky MI, Beckermann KE, Davis NB, Haake SM, Karam JA, Bortone DS, Vincent BG, et al. Neoadjuvant pazopanib and molecular analysis of tissue response in renal cell carcinoma. Jci Insight. 5. PMID 33208553 DOI: 10.1172/jci.insight.132852  0.31
2020 Bortone DS, Woodcock MG, Parker JS, Vincent BG. Improved T cell receptor diversity estimates associate with survival and response to anti-PD-1 therapy. Cancer Immunology Research. PMID 33177107 DOI: 10.1158/2326-6066.CIR-20-0398  0.347
2020 Das M, Zhou X, Liu Y, Das A, Vincent BG, Li J, Liu R, Huang L. Tumor neoantigen heterogeneity impacts bystander immune inhibition of pancreatic cancer growth. Translational Oncology. 13: 100856. PMID 32862105 DOI: 10.1016/J.Tranon.2020.100856  0.378
2020 Beckermann KE, Hongo R, Ye X, Young K, Carbonell K, Healey DCC, Siska PJ, Barone S, Roe CE, Smith CC, Vincent BG, Mason FM, Irish JM, Rathmell WK, Rathmell JC. CD28 costimulation drives tumor-infiltrating T cell glycolysis to promote inflammation. Jci Insight. 5. PMID 32814710 DOI: 10.1172/Jci.Insight.138729  0.756
2020 Crosby EJ, Acharya CR, Haddad AF, Rabiola CA, Lei G, Wei JP, Yang XY, Wang T, Liu CX, Wagner KU, Muller WJ, Chodosh LA, Broadwater G, Hyslop T, Shepherd JH, ... ... Vincent BG, et al. Stimulation of Oncogene-Specific Tumor-Infiltrating T Cells through Combined Vaccine and αPD-1 Enable Sustained Antitumor Responses against Established HER2 Breast Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32732224 DOI: 10.1158/1078-0432.Ccr-20-0389  0.334
2020 Smith CC, Entwistle S, Willis C, Vensko S, Beck W, Garness J, Sambade M, Routh E, Olsen K, Kodysh J, O'Donnell T, Haber C, Heiss K, Stadler V, Garrison E, ... ... Vincent BG, et al. Landscape and Selection of Vaccine Epitopes in SARS-CoV-2. Biorxiv : the Preprint Server For Biology. PMID 32577654 DOI: 10.1101/2020.06.04.135004  0.764
2020 Mirlekar B, Michaud D, Lee SJ, Kren NP, Harris C, Greene K, Goldman EC, Gupta GP, Fields RC, Hawkins WG, DeNardo DG, Rashid NU, Yeh JJ, McRee AJ, Vincent BG, et al. B cell-Derived IL35 Drives STAT3-Dependent CD8 T-cell Exclusion in Pancreatic Cancer. Cancer Immunology Research. PMID 32024640 DOI: 10.1158/2326-6066.CIR-19-0349  0.392
2020 Ma X, Shou P, Smith C, Chen Y, Du H, Sun C, Porterfield Kren N, Michaud D, Ahn S, Vincent B, Savoldo B, Pylayeva-Gupta Y, Zhang S, Dotti G, Xu Y. Interleukin-23 engineering improves CAR T cell function in solid tumors. Nature Biotechnology. PMID 32015548 DOI: 10.1038/s41587-019-0398-2  0.761
2020 Zhu J, Patel T, Miller JA, Torrice CD, Aggarwal M, Sketch MR, Alexander MD, Armistead PM, Coghill JM, Grgic T, Jamieson KJ, Ptachcinski JR, Riches ML, Serody JS, Schmitz JL, ... ... Vincent BG, et al. Influence of Germline Genetics on Tacrolimus Pharmacokinetics and Pharmacodynamics in Allogeneic Hematopoietic Stem Cell Transplant Patients. International Journal of Molecular Sciences. 21. PMID 32013193 DOI: 10.3390/Ijms21030858  0.478
2019 Piper C, Zhou V, Komorowski R, Szabo A, Vincent B, Serody J, Alegre ML, Edelson BT, Taneja R, Drobyski WR. Pathogenic Bhlhe40+ GM-CSF+ CD4+ T Cells Promote Indirect Alloantigen Presentation in the GI Tract during GVHD. Blood. PMID 31880771 DOI: 10.1182/Blood.2019001696  0.577
2019 Hollern DP, Xu N, Thennavan A, Glodowski C, Garcia-Recio S, Mott KR, He X, Garay JP, Carey-Ewend K, Marron D, Ford J, Liu S, Vick SC, Martin M, Parker JS, ... Vincent BG, et al. B Cells and T Follicular Helper Cells Mediate Response to Checkpoint Inhibitors in High Mutation Burden Mouse Models of Breast Cancer. Cell. 179: 1191-1206.e21. PMID 31730857 DOI: 10.1016/J.Cell.2019.10.028  0.631
2019 Landoni E, Smith CC, Fucá G, Chen Y, Sun C, Vincent BG, Metelitsa LS, Dotti G, Savoldo B. A High Avidity T-Cell Receptor Redirects Natural Killer T-Cell Specificity and Outcompetes the Endogenous Invariant T-Cell Receptor. Cancer Immunology Research. PMID 31719055 DOI: 10.1158/2326-6066.CIR-19-0134  0.78
2019 Li C, Zhu B, Son YM, Wang Z, Jiang L, Xiang M, Ye Z, Beckermann KE, Wu Y, Jenkins JW, Siska PJ, Vincent BG, Prakash YS, Peikert T, Edelson BT, et al. The Transcription Factor Bhlhe40 Programs Mitochondrial Regulation of Resident CD8 T Cell Fitness and Functionality. Immunity. 51: 491-507.e7. PMID 31533057 DOI: 10.1016/J.Immuni.2019.08.013  0.377
2019 Smith CC, Chai S, Washington AR, Lee SJ, Landoni E, Field K, Garness J, Bixby LM, Selitsky SR, Parker JS, Savoldo B, Serody JS, Vincent BG. Machine-Learning Prediction of Tumor Antigen Immunogenicity in the Selection of Therapeutic Epitopes. Cancer Immunology Research. PMID 31515258 DOI: 10.1158/2326-6066.Cir-19-0155  0.793
2019 Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, Ziv E, Culhane AC, Paull EO, Sivakumar IKA, Gentles AJ, ... ... Vincent BG, et al. The Immune Landscape of Cancer. Immunity. 51: 411-412. PMID 31433971 DOI: 10.1016/J.Immuni.2019.08.004  0.522
2019 Free ME, Stember KG, Hess JJ, McInnis EA, Lardinois O, Hogan SL, Hu Y, Mendoza C, Le AK, Guseman AJ, Pilkinton MA, Bortone DS, Cowens K, Sidney J, Karosiene E, ... ... Vincent BG, et al. Restricted myeloperoxidase epitopes drive the adaptive immune response in MPO-ANCA vasculitis. Journal of Autoimmunity. 102306. PMID 31383567 DOI: 10.1016/J.Jaut.2019.102306  0.359
2019 Smith CC, Selitsky SR, Chai S, Armistead PM, Vincent BG, Serody JS. Alternative tumour-specific antigens. Nature Reviews. Cancer. PMID 31278396 DOI: 10.1038/S41568-019-0162-4  0.759
2019 Selitsky SR, Mose LE, Smith CC, Chai S, Hoadley KA, Dittmer DP, Moschos SJ, Parker JS, Vincent BG. Prognostic value of B cells in cutaneous melanoma. Genome Medicine. 11: 36. PMID 31138334 DOI: 10.1186/S13073-019-0647-5  0.762
2018 Davis JM, Ivanova A, Chung Y, Shaw JR, Rao K, Sharf JP, Serody J, Armistead P, Wood WA, Coghill J, Jamieson K, Vincent BG, Riches M, Shea T, Alexander M. Evaluation of a Test Dose Strategy for Pharmacokinetically-guided Busulfan Dosing for Hematopoietic Stem Cell Transplant. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 30244102 DOI: 10.1016/J.Bbmt.2018.09.017  0.43
2018 Smith CC, Beckermann KE, Bortone DS, de Cubas AA, Bixby LM, Lee SJ, Panda A, Ganesan S, Bhanot G, Wallen EM, Milowsky MI, Kim WY, Rathmell WK, Swanstrom R, Parker JS, ... ... Vincent BG, et al. Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma. The Journal of Clinical Investigation. PMID 30137025 DOI: 10.1172/Jci121476  0.815
2018 Panda A, de Cubas AA, Stein M, Riedlinger G, Kra J, Mayer T, Smith CC, Vincent BG, Serody JS, Beckermann KE, Ganesan S, Bhanot G, Rathmell WK. Endogenous retrovirus expression is associated with response to immune checkpoint blockade in clear cell renal cell carcinoma. Jci Insight. 3. PMID 30135306 DOI: 10.1172/Jci.Insight.121522  0.806
2018 Hong LK, Chen Y, Smith CC, Montgomery SA, Vincent BG, Dotti G, Savoldo B. CD30-Redirected Chimeric Antigen Receptor T Cells Target CD30+ and CD30- Embryonal Carcinoma via Antigen-dependent and Fas/FasL Interactions. Cancer Immunology Research. PMID 30087115 DOI: 10.1158/2326-6066.CIR-18-0065  0.779
2018 Smithey MJ, Venturi V, Davenport MP, Buntzman AS, Vincent BG, Frelinger JA, Nikolich-Žugich J. Lifelong CMV infection improves immune defense in old mice by broadening the mobilized TCR repertoire against third-party infection. Proceedings of the National Academy of Sciences of the United States of America. PMID 29967140 DOI: 10.1073/Pnas.1719451115  0.551
2018 Ricketts CJ, De Cubas AA, Fan H, Smith CC, Lang M, Reznik E, Bowlby R, Gibb EA, Akbani R, Beroukhim R, Bottaro DP, Choueiri TK, Gibbs RA, Godwin AK, Haake S, ... ... Vincent BG, et al. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Reports. 23: 3698. PMID 29925010 DOI: 10.1016/J.Celrep.2018.06.032  0.729
2018 Saito R, Smith CC, Utsumi T, Bixby LM, Kardos J, Wobker SE, Stewart KG, Chai S, Manocha U, Byrd KM, Damrauer JS, Williams SE, Vincent BG, Kim WY. Molecular subtype-specific immunocompetent models of high-grade urothelial carcinoma reveal differential neoantigen expression and response to immunotherapy. Cancer Research. PMID 29784854 DOI: 10.1158/0008-5472.CAN-18-0173  0.777
2018 Agle K, Vincent BG, Piper C, Belle L, Zhou V, Shlomchik W, Serody JS, Drobyski WR. Bim regulates the survival and suppressive capability of CD8 FOXP3 regulatory T cells during murine GVHD. Blood. PMID 29769260 DOI: 10.1182/Blood-2017-09-807156  0.566
2018 Mi Y, Smith CC, Yang F, Qi Y, Roche KC, Serody JS, Vincent BG, Wang AZ. A Dual Immunotherapy Nanoparticle Improves T-Cell Activation and Cancer Immunotherapy. Advanced Materials (Deerfield Beach, Fla.). e1706098. PMID 29691900 DOI: 10.1002/Adma.201706098  0.797
2018 Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, Ziv E, Culhane AC, Paull EO, Sivakumar IKA, Gentles AJ, ... ... Vincent BG, et al. The Immune Landscape of Cancer. Immunity. PMID 29628290 DOI: 10.1016/J.Immuni.2018.03.023  0.602
2018 Ricketts CJ, De Cubas AA, Fan H, Smith CC, Lang M, Reznik E, Bowlby R, Gibb EA, Akbani R, Beroukhim R, Bottaro DP, Choueiri TK, Gibbs RA, Godwin AK, Haake S, ... ... Vincent BG, et al. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Reports. 23: 313-326.e5. PMID 29617669 DOI: 10.1016/J.Celrep.2018.03.075  0.749
2018 Beckford Vera DR, Smith CC, Bixby LM, Glatt DM, Dunn SS, Saito R, Kim WY, Serody JS, Vincent BG, Parrott MC. Immuno-PET imaging of tumor-infiltrating lymphocytes using zirconium-89 radiolabeled anti-CD3 antibody in immune-competent mice bearing syngeneic tumors. Plos One. 13: e0193832. PMID 29513764 DOI: 10.1371/Journal.Pone.0193832  0.801
2017 Pearce OMT, Delaine-Smith R, Maniati E, Nichols S, Wang J, Böhm S, Rajeeve V, Ullah D, Chakravarty P, Jones RR, Montfort A, Dowe T, Gribben J, Jones JL, Kocher HM, ... ... Vincent BG, et al. Deconstruction of a metastatic tumor microenvironment reveals a common matrix response in human cancers. Cancer Discovery. PMID 29196464 DOI: 10.1158/2159-8290.Cd-17-0284  0.529
2017 Poe JC, Jia W, Su H, Anand S, Rose JJ, Tata PV, Suthers AN, Jones CD, Kuan PF, Vincent BG, Serody JS, Horwitz ME, Ho VT, Pavletic SZ, Hakim FT, et al. An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD. Blood. PMID 28851699 DOI: 10.1182/Blood-2017-05-782466  0.546
2017 Taylor NA, Vick SC, Iglesia MD, Brickey WJ, Midkiff BR, McKinnon KP, Reisdorf S, Anders CK, Carey LA, Parker JS, Perou CM, Vincent BG, Serody JS. Treg depletion potentiates checkpoint inhibition in claudin-low breast cancer. The Journal of Clinical Investigation. PMID 28825599 DOI: 10.1172/Jci90499  0.631
2017 Min Y, Roche KC, Tian S, Eblan MJ, McKinnon KP, Caster JM, Chai S, Herring LE, Zhang L, Zhang T, DeSimone JM, Tepper JE, Vincent BG, Serody JS, Wang AZ. Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy. Nature Nanotechnology. PMID 28650437 DOI: 10.1038/Nnano.2017.113  0.571
2017 Siska PJ, Beckermann KE, Mason FM, Andrejeva G, Greenplate AR, Sendor AB, Chiang YJ, Corona AL, Gemta LF, Vincent BG, Wang RC, Kim B, Hong J, Chen CL, Bullock TN, et al. Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma. Jci Insight. 2. PMID 28614802 DOI: 10.1172/Jci.Insight.93411  0.381
2017 Dant TA, Lin KL, Bruce DW, Montgomery SA, Kolupaev OV, Bommiasamy H, Bixby LM, Woosley JT, McKinnon KP, Gonzalez FJ, Blazar BR, Vincent BG, Coghill JM, Serody JS. T cell expression of AhR inhibits the maintenance of pTreg cells in the GI tract in acute GvHD. Blood. PMID 28550042 DOI: 10.1182/Blood-2016-08-734244  0.61
2017 Bruce DW, Stefanski HE, Vincent BG, Dant TA, Reisdorf S, Bommiasamy H, Serody DA, Wilson JE, McKinnon KP, Shlomchik WD, Armistead PM, Ting JP, Woosley JT, Blazar BR, Zaiss DM, et al. Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease. The Journal of Clinical Investigation. PMID 28375154 DOI: 10.1172/Jci91816  0.651
2016 Mose LE, Selitsky SR, Bixby LM, Marron DL, Iglesia MD, Serody JS, Perou CM, Vincent BG, Parker JS. Assembly-based inference of B-cell receptor repertoires from short read RNA sequencing data with V'DJer. Bioinformatics (Oxford, England). PMID 27559159 DOI: 10.1093/Bioinformatics/Btw526  0.492
2016 Zhou V, Agle K, Chen X, Beres A, Komorowski R, Belle L, Taylor C, Zhu F, Haribhai D, Williams CB, Verbsky J, Blumenschein W, Sadekova S, Bowman E, Ballantyne C, ... ... Vincent B, et al. A colitogenic memory CD4+ T cell population mediates gastrointestinal graft-versus-host disease. The Journal of Clinical Investigation. PMID 27500496 DOI: 10.1172/Jci80874  0.587
2016 Montfort A, Pearce OM, Maniati E, Vincent B, Bixby LM, Böhm S, Dowe T, Wilkes EH, Chakravarty P, Thompson R, Topping J, Cutillas PR, Lockley M, Serody JS, Capasso M, et al. A strong B cell response is part of the immune landscape in human high-grade serous ovarian metastases. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27354470 DOI: 10.1158/1078-0432.Ccr-16-0081  0.628
2016 Iglesia MD, Parker JS, Hoadley KA, Serody JS, Perou CM, Vincent BG. Genomic Analysis of Immune Cell Infiltrates Across 11 Tumor Types. Journal of the National Cancer Institute. 108. PMID 27335052 DOI: 10.1093/Jnci/Djw144  0.567
2016 Saha A, O'Connor RS, Thangavelu G, Lovitch SB, Dandamudi DB, Wilson CB, Vincent BG, Tkachev V, Pawlicki JM, Furlan SN, Kean LS, Aoyama K, Taylor PA, Panoskaltsis-Mortari A, Foncea R, et al. Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality. The Journal of Clinical Investigation. PMID 27294527 DOI: 10.1172/Jci85796  0.555
2015 Vincent B, Buntzman A, Hopson B, McEwen C, Cowell L, Akoglu A, Zhang H, Frelinger J. iWAS - A novel approach to analyzing Next Generation Sequence data for immunology. Cellular Immunology. PMID 26547365 DOI: 10.1016/J.Cellimm.2015.10.012  0.547
2015 Hunsucker SA, McGary CS, Vincent BG, Enyenihi AA, Waugh JP, McKinnon KP, Bixby LM, Ropp PA, Coghill JM, Wood WA, Gabriel DA, Sarantopoulos S, Shea TC, Serody JS, Alatrash G, et al. Peptide/MHC tetramer-based sorting of CD8⁺ T cells to a leukemia antigen yields clonotypes drawn nonspecifically from an underlying restricted repertoire. Cancer Immunology Research. 3: 228-35. PMID 25576336 DOI: 10.1158/2326-6066.Cir-14-0001  0.714
2014 Iglesia MD, Vincent BG, Parker JS, Hoadley KA, Carey LA, Perou CM, Serody JS. Prognostic B-cell signatures using mRNA-seq in patients with subtype-specific breast and ovarian cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 3818-29. PMID 24916698 DOI: 10.1158/1078-0432.Ccr-13-3368  0.575
2013 Hess SM, Young EF, Miller KR, Vincent BG, Buntzman AS, Collins EJ, Frelinger JA, Hess PR. Deletion of naïve T cells recognizing the minor histocompatibility antigen HY with toxin-coupled peptide-MHC class I tetramers inhibits cognate CTL responses and alters immunodominance. Transplant Immunology. 29: 138-45. PMID 24161680 DOI: 10.1016/J.Trim.2013.10.005  0.611
2013 Coghill JM, Fowler KA, West ML, Fulton LM, van Deventer H, McKinnon KP, Vincent BG, Lin K, Panoskaltsis-Mortari A, Cook DN, Blazar BR, Serody JS. CC chemokine receptor 8 potentiates donor Treg survival and is critical for the prevention of murine graft-versus-host disease. Blood. 122: 825-36. PMID 23798714 DOI: 10.1182/Blood-2012-06-435735  0.534
2013 Vincent BG, Serody JS. One is better than two: TCR pairing and GVHD. Science Translational Medicine. 5: 188fs21. PMID 23740895 DOI: 10.1126/Scitranslmed.3006431  0.508
2012 Diz R, Garland A, Vincent BG, Johnson MC, Spidale N, Wang B, Tisch R. Autoreactive effector/memory CD4+ and CD8+ T cells infiltrating grafted and endogenous islets in diabetic NOD mice exhibit similar T cell receptor usage. Plos One. 7: e52054. PMID 23251685 DOI: 10.1371/Journal.Pone.0052054  0.339
2012 Bunztman A, Vincent BG, Krovi H, Steele S, Frelinger JA. The LCMV gp33-specific memory T cell repertoire narrows with age. Immunity & Ageing : I & A. 9: 17. PMID 22894656 DOI: 10.1186/1742-4933-9-17  0.589
2012 Gojanovich GS, Murray SL, Buntzman AS, Young EF, Vincent BG, Hess PR. The use of peptide-major-histocompatibility-complex multimers in type 1 diabetes mellitus. Journal of Diabetes Science and Technology. 6: 515-24. PMID 22768881 DOI: 10.1177/193229681200600305  0.332
2010 Vincent BG, Young EF, Buntzman AS, Stevens R, Kepler TB, Tisch RM, Frelinger JA, Hess PR. Toxin-coupled MHC class I tetramers can specifically ablate autoreactive CD8+ T cells and delay diabetes in nonobese diabetic mice. Journal of Immunology (Baltimore, Md. : 1950). 184: 4196-204. PMID 20220085 DOI: 10.4049/Jimmunol.0903931  0.589
2008 Riddle DS, Miller PJ, Vincent BG, Kepler TB, Maile R, Frelinger JA, Collins EJ. Rescue of cytotoxic function in the CD8alpha knockout mouse by removal of MHC class II. European Journal of Immunology. 38: 1511-21. PMID 18465769 DOI: 10.1002/Eji.200737710  0.548
Show low-probability matches.